India's retail pharmacy market is worth ₹2.4 lakh crore and growing at 9% annually. The generic medicine segment within it is growing at 18% — twice the rate of branded medicines. Consumers are waking up to the fact that they've been overpaying for decades.
If you're considering a pharmacy franchise, here's what the numbers actually look like in 2026.
Why a generic medicine pharmacy makes sense in 2026
- Underserved demand — most cities still don't have a dedicated generic pharmacy
- Government push — Jan Aushadhi initiative has primed consumer awareness
- Recurring revenue — chronic disease patients buy every month for life
- Higher margins than retailing branded medicines (because you cut out distributor markup)
- Add-on services — lab tests, doctor consultations, subscription refills add ₹40-80k/month
Realistic investment & returns
| Component | Cost |
|---|---|
| Initial inventory (mixed generic + OTC) | ₹2,00,000 – 3,00,000 |
| Interior + shelving + signage | ₹80,000 – 1,50,000 |
| POS + computer + barcode | ₹40,000 – 60,000 |
| Pharma-grade cold storage | ₹25,000 – 40,000 |
| Initial license fees + deposits | ₹15,000 – 30,000 |
| Pre-launch marketing | ₹30,000 – 70,000 |
| Working capital (3 months) | ₹50,000 – 1,00,000 |
| Total typical investment | ₹4,40,000 – 8,00,000 |
Monthly revenue (typical Tier-2 city, 250 sq.ft shop, 6 months operational):
| Revenue stream | Monthly |
|---|---|
| Chronic-care medicines (recurring) | ₹1,50,000 – 2,80,000 |
| Acute / one-off medicines | ₹40,000 – 80,000 |
| OTC / supplements / wellness | ₹35,000 – 70,000 |
| Lab tests + home collection | ₹40,000 – 80,000 |
| Total monthly revenue | ₹2,65,000 – 5,10,000 |
Typical monthly profit:
At 30% gross margin and 12% operating costs (rent, staff, electricity), monthly net profit is ₹40,000 – 90,000 — depending on location and footfall.
Payback period: 10–14 months for most stores.
Legal requirements
- Retail Drug License (Form 20B) — from your state Drug Controller. Requires:
- Qualified pharmacist (D.Pharm/B.Pharm) registered with state council
- Minimum 120 sq.ft shop area
- Specified cold storage
- Shop & Establishment registration
- GST registration (mandatory above ₹40 lakh turnover, recommended from day 1)
- FSSAI (only if selling nutraceuticals / supplements)
- Shop & Establishment Act registration with municipal corporation
- Trade License from local body
What AsliMeds franchise includes
When you partner with AsliMeds, you get:
- Pre-vetted inventory of WHO-GMP generic medicines + competitive wholesale prices
- Free POS billing software, inventory management, customer app
- Pre-launch marketing playbook (Google Ads, hyperlocal SMS, local event)
- Pharmacist hiring and training support
- Regulatory help — licenses, compliance, audits
- Lab tests revenue stream activated from day 1
- Ongoing partner desk support via WhatsApp
- Net 15-day credit on stock orders
How long does it take to open?
| Week | Activity |
|---|---|
| 1–2 | Application, site visit, agreement signing |
| 3–6 | Drug license application (in parallel with shop fit-out) |
| 4–7 | Interior work, signage, POS install, staff hiring |
| 7–8 | License approval, initial stock delivery, soft launch |
| 8 | Grand opening with local marketing campaign |
Typical timeline: 6-8 weeks from application to opening.
Common questions from prospective franchisees
Do I need pharmacy experience?
No — you need a qualified pharmacist on staff (we help you hire one). You as the owner manage the business side. Many of our partners are first-time entrepreneurs or existing retail owners.
What if I already own a pharmacy?
Conversion is the easiest path. You keep your existing license, customers, and shop. We help you switch to a generic-first inventory model + add lab tests + activate online ordering. Most converted shops see 40-60% revenue uplift within 6 months.
Is there an exclusive territory?
Yes — we don't open another AsliMeds franchise within a 3 km radius of yours in Tier-2 cities (1 km in metros).
What's the franchise fee?
One-time partner fee is modest and rolled into your investment. There's no ongoing royalty for the first year. After that, a small revenue-share on technology + marketing services. Full economics shared in our partner deck.
